# Characterize Flu-like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Non-Pegylated Interferon Beta (IFN-β) Therapies to Peginterferon Beta-1a (BIIB017)

> **NCT01939002** · PHASE3 · COMPLETED · sponsor: **Biogen** · enrollment: 251 (actual)

## Conditions studied

- Relapsing Multiple Sclerosis

## Interventions

- **DRUG:** BIIB017
- **DRUG:** naproxen

## Key facts

- **NCT ID:** NCT01939002
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2015-10
- **Final completion:** 2015-11
- **Target enrollment:** 251 (ACTUAL)
- **Last updated:** 2017-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01939002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01939002, "Characterize Flu-like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Non-Pegylated Interferon Beta (IFN-β) Therapies to Peginterferon Beta-1a (BIIB017)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01939002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*